Obesity, by definition, is a Body Mass Index (BMI) of 30 kg per square meter or greater. The prevalence of obesity has increased and is now thought to affect more than one third of the adult population. Recent studies have shown that obesity has an adverse effect on microcirculation and is an important risk factor for the development of many health problems, such as metabolic syndrome (insulin resistance, elevated lipid levels, high blood pressure and increased abdominal girth), ischemic heart disease, heart failure, and other cardiovascular diseases.
The following case demonstrates how improving microcirculation can help with weight reduction in obese people.
Brenda V was a 39-year-old white female patient with severe obesity and a BMI of 52.4 kilograms per square meter. Brenda’s past medical history was significant because it included a history of morbid obesity, high cholesterol, high blood pressure, diabetes mellitus, gout, and depression. She revealed that she could only walk for one block without severe shortness of breath and had to sleep on 2 pillows at night.
On physical examination, her weight was 340 pounds, and her height was 5 feet, 1 inch. Her blood pressure was 180/105, and her cardiovascular exam revealed severe pitting edema of both legs.
Brenda’s abdomen was distended and morbidly obese with decreased bowel sounds. Her laboratory exam showed a hemoglobin A1C level of 12.5% (normal is less than 5.7%) and a triglyceride level of 600 mg/dl (normal is less than 150 mg/dl).
Brenda was put on a regimen of diet, increased exercise, and the use of the peripheral deoxyhemoglobin vasodilator D’OXYVA for 5 minutes per day, 5 times a week, for a 3 month period. After the regular applications, she had the following improvements:
- Increased physical activity
- Decreased blood sugar levels
- Decreased blood pressure
- Decreased triglyceride levels
- Decreased HgbA1C levels
- Increased cardiac function
- Increased endurance
- Increased physical fitness
- Decreased depression
- Massively decreased weight
- Increased mobility
YOU MAY ALSO LIKE
- Apple Watch 4 can detect D’OXYVA’s benefits
- Researchers Identify Underlying Main Causes of Brain Damage, Dementia and Potential Breakthrough Solution (Part I)
- Award-winning documentary hosted by actor Dennis Quaid invites Circularity to talk about D’OXYVA
How Does Obesity Affect Microcirculation?
Microcirculation refers to the body’s smallest branching blood vessels (arterioles, venules, and capillaries with internal diameters less than 100 microns) that supply oxygen to and remove wastes products from the body’s tissues.
Microcirculation responds to changes in metabolic demands or sympathetic nervous system activation by either expanding or contracting to increase or decrease perfusion levels.
Early in the course of obesity, dysfunctional changes begin to appear in microcirculatory endothelial lining cells”.
These changes are caused by oxidative stress and inflammation of the microcirculation and are now thought to lead to both insulin resistance and hypertension.
Obesity has been found to lead to microcirculatory dysfunction, which causes severe health problems, such as metabolic syndrome, diabetes mellitus and various cardiovascular diseases. Reducing obesity through a program of strict dietary control, increased exercise and the use of D’OXYVA to enhance microcirculation can significantly improve general health and reduce the risk of potentially lethal health complications.
HOW D’OXYVA® CAN HELP?
D’OXYVA is the only fully noninvasive, completely painless over-the-skin microcirculatory solution that has been validated to significantly improve microcirculation. The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.